[artículo]
| Título : |
Rapid dose escalation with quetiapine a pilot study |
| Tipo de documento: |
texto impreso |
| Autores: |
Mark A. Smith, Autor ; Robin McCoy, Autor ; Jennifer Hamer Maansson, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 331-335 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antipsicóticos, Dibenzotiacepinas, Fumarato de quetiapina, Esquizofrenia. |
| Resumen: |
The original dosing recommendations for quetiapine in the treatment of schizophrenia suggested escalation to 400 mg/d using the following schedule, administered twice daily in divided doses: Day 1, 50 mg; Day 2, 100 mg; Day 3, 200 mg; Day 4, 300 mg; Day 5, 400 mg. In practice, however, clinicians often exceed these recommendations because of the need to obtain a therapeutic response in patients with psychosis as quickly as possible. |
| Link: |
./index.php?lvl=notice_display&id=30898 |
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 331-335
[artículo] Rapid dose escalation with quetiapine a pilot study [texto impreso] / Mark A. Smith, Autor ; Robin McCoy, Autor ; Jennifer Hamer Maansson, Autor . - 2023 . - pp. 331-335. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 4 (Agosto) . - pp. 331-335
| Palabras clave: |
Antipsicóticos, Dibenzotiacepinas, Fumarato de quetiapina, Esquizofrenia. |
| Resumen: |
The original dosing recommendations for quetiapine in the treatment of schizophrenia suggested escalation to 400 mg/d using the following schedule, administered twice daily in divided doses: Day 1, 50 mg; Day 2, 100 mg; Day 3, 200 mg; Day 4, 300 mg; Day 5, 400 mg. In practice, however, clinicians often exceed these recommendations because of the need to obtain a therapeutic response in patients with psychosis as quickly as possible. |
| Link: |
./index.php?lvl=notice_display&id=30898 |
|
Refinar búsquedaRapid dose escalation with quetiapine a pilot study en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 4 (Agosto)
